Amelenodor is under clinical development by AbbVie and currently in Phase I for Crohn's Disease (Regional Enteritis).

ATOPIC dermatitis (AD), a chronic inflammatory skin condition, affects millions globally and is linked to systemic immune ...

Nov. 19, 2024 — A study provides insights into the diversity of cancer-associated fibroblasts in white and black skin cancer and describes their different immunomodulatory roles in the tumor ...

Medically reviewed by Qin Rao, MD Pancolitis, or extensive colitis, is a form of ulcerative colitis (UC) in which ...

MK-6194 is under clinical development by Merck and currently in Phase II for Ulcerative Colitis. According to GlobalData, Phase II drugs for Ulcerative Colitis have a 45% phase transition success rate ...

Steqeyma is approved for adult and pediatric patients with plaque psoriasis and active psoriatic arthritis as well as adults ...

An ostomy is a surgical procedure creating an opening, or "stoma," on the abdomen to allow waste to exit the body. This may ...

Acne is the most common skin condition in the United States, affecting up to 50 million Americans annually. 1 There are different types of acne (blackheads, whiteheads, pimples, acne cysts or nodules) ...

Clostridioides difficile (C. diff) is a bacterial infection that commonly affects people with ulcerative colitis (UC). It can worsen symptoms and cause complications. It can also trigger a ...

Ulcerative colitis is a chronic relapsing and remitting inflammatory disorder that can generally be managed successfully with maintenance oral medications. However, approximately 15% of patients ...

Buruli ulcer, also known as Bairnsdale ulcer, is a bacterial infection caused by Mycobacterium ulcerans. It leads to a progressive infection that damages the skin and soft tissue. The infection ...

COVID-19 might be a trigger for new ulcerative colitis for some people. It may also be a trigger for symptom flare-ups for people previously diagnosed with UC. COVID-19 is a respiratory illness ...